Alimentiv, formerly known as Robarts Clinical Trials, is a specialized gastrointestinal clinical research organization supporting pharmaceutical and biotechnology sponsors with full-service GI clinical trial execution, central imaging, biomarkers, precision medicine, statistics, and clinical development support. The company is focused exclusively on gastrointestinal research, with deep experience across inflammatory bowel disease and other upper and lower GI indications.

Overview

Alimentiv is built for sponsors developing GI therapeutics that need more than a generalist CRO. Their model combines clinical trial operations, scientific strategy, medical imaging, endpoint expertise, biomarker services, and statistical support for complex gastrointestinal studies.

For biotech and pharma teams working in ulcerative colitis, Crohn’s disease, eosinophilic esophagitis, celiac disease, NASH/MASH, and other GI-related indications, Alimentiv offers a focused clinical development partner with the infrastructure and disease-specific expertise to support global trials.

Accreditations & Compliance

Alimentiv supports regulated clinical research programs across global GI trials, with services spanning clinical operations, central imaging, biomarkers, medical writing, statistics, and regulatory submission support. Their central reading and endpoint models are designed specifically for IBD and GI-related diseases, including endoscopy, histology, MRE, and intestinal ultrasound workflows.

For project-specific studies, sponsors should confirm protocol requirements, regional regulatory needs, imaging standards, central reader expectations, endpoint adjudication procedures, data transfer requirements, and submission-ready documentation before study launch.

Core Services

Alimentiv provides full-service gastroenterology clinical trial services from protocol design through trial execution and regulatory submission support. Their offering includes clinical study management, medical monitoring, site support, data management, statistics, medical writing, precision medicine, biomarkers, and medical imaging solutions.

Their medical imaging services are a major strength, particularly for GI trials that require standardized endoscopy scoring, histology assessment, magnetic resonance enterography, intestinal ultrasound, and central reading workflows. Alimentiv’s central reading model is built specifically for IBD and related GI diseases.

Alimentiv also supports precision medicine and biomarker-driven clinical trial programs through GI-focused laboratory and translational research capabilities, including histopathology and advanced endpoint development.

Technology & Expertise

Alimentiv’s expertise is centered on gastrointestinal clinical development. Their team brings experience in study design, endpoint strategy, central reading, imaging standardization, patient enrollment, site activation, and trial execution across GI indications.

A key part of their value is their ability to support validated and standardized endpoints in GI trials. This includes endoscopic scoring, histology, noninvasive imaging, intestinal ultrasound, MRE, and emerging AI-assisted image analysis tools for ulcerative colitis and other GI conditions.

Alimentiv also reports access to more than 5,000 sites across over 60 countries and states that it has supported more than 70% of IBD compounds in development, making them a strong fit for sponsors that need global trial reach with GI-specific expertise.

Best Fit Projects

Alimentiv is a strong fit for clinical studies involving inflammatory bowel disease, Crohn’s disease, ulcerative colitis, eosinophilic esophagitis, celiac disease, MASH/NASH, GI imaging endpoints, endoscopy scoring, histology, MRE, intestinal ultrasound, biomarker strategy, precision medicine, and global GI trial operations.

They are especially well suited for sponsors that need a specialized GI CRO rather than a broad clinical research provider.

Why Work With Alimentiv Through CROaccess

Through CROaccess, sponsors can evaluate Alimentiv for GI-focused clinical trials, central imaging, biomarker strategy, endpoint development, and precision medicine support while comparing fit against other qualified CROs and specialty clinical research vendors.

Alimentiv brings deep gastrointestinal clinical trial expertise, while CROaccess helps sponsors manage vendor evaluation, proposal collection, documentation, communication, and project tracking in one centralized platform.